Researchers from Rochester, Minn.-based Mayo Clinic and Stanford (Calif.) Medicine have developed a blood test capable of mapping cancer cell ecosystems to predict immunotherapy response, according to a study published May 6 in Nature.
Certain cell ecosystems, or neighborhoods, are associated with different survival and immunotherapy response outcomes. Changes in these neighborhoods can signal treatment response or resistance “months before traditional imaging,” Mayo Clinic said in a May 6 news release.
The initial study involved more than 1,300 patients across multiple cancer types. Future studies are being conducted to validate the blood test in larger patient populations and integrate the test into clinical care, the release said.
Read the full study here.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
